A study of prolonged jaundice screen in healthy term babies

Mahendra Kumar Banakar1, Anbu Subbarayan

  • 1Department of Pediatrics, Wythenshawe Hospital, Southmoor Road, Manchester, UK M23 9LT.

Insights

A negative prolonged jaundice screen is reassuring for healthy term infants, helping to rule out serious conditions like biliary atresia. Further investigations are typically unnecessary unless specific concerns arise.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Clinical Diagnostics

Background:

  • Prolonged jaundice in term infants can indicate serious underlying disorders, necessitating timely diagnosis.
  • While often linked to breast milk, conjugated hyperbilirubinemia requires urgent investigation for potential hepatobiliary, metabolic, or genetic conditions.
  • Current protocols for investigating prolonged jaundice vary, and their diagnostic yield requires assessment.

Purpose of the Study:

  • To evaluate the utility of a prolonged jaundice screen in healthy term infants.
  • To determine if the established screening protocol effectively differentiates benign causes from serious pathologies.
  • To assess the diagnostic yield and clinical impact of the prolonged jaundice screening protocol.

Main Methods:

  • A study was conducted on healthy term babies presenting with prolonged jaundice.
  • Infants underwent examination by a pediatrician and investigations according to a defined unit protocol.
  • The diagnostic accuracy and effectiveness of the prolonged jaundice screen were analyzed.

Main Results:

  • The prolonged jaundice screen proved effective in excluding biliary atresia.
  • The screen supported the diagnosis of breast milk jaundice.
  • A negative screen provided reassurance for healthy term infants.

Conclusions:

  • A negative prolonged jaundice screen is a reliable indicator in healthy term babies.
  • Further extensive investigations are generally not warranted for healthy term infants with a negative screen.
  • The study supports the use of the current protocol for initial assessment of prolonged jaundice.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...